Takata T, Zhao M, Uchida T, Wang T, Aoki T, Bartlett J D, Nikai H
Department of Oral Pathology, Faculty of Dentistry, Hiroshima University, Japan.
J Dent Res. 2000 Aug;79(8):1608-13. doi: 10.1177/00220345000790081401.
Enamelysin is a tooth-specific protease that was initially isolated from porcine enamel organ and subsequently from human odontoblasts. Since this protease is thought to play important roles in tooth development, the evaluation of enamelysin in odontogenic tumors may aid our understanding of the histogenesis and cell differentiation of such lesions. A monoclonal antibody (203-1C7) was generated against synthesized human enamelysin oligopeptide and was used to assess the immunolocalization of enamelysin in healthy developing tooth germs and various types of odontogenic lesions. In tooth germs, enamelysin expression was detected only in the secretory enamel. Thus, 203-1C7 may serve as an enamel-specific marker in the late stage of enamel matrix development and calcification. In odontogenic lesions, strong enamelysin staining was demonstrated in the immature enamel matrix of ameloblastic fibro-odontomas and odontomas. Furthermore, enamelysin was also detected in globular amyloid masses and calcified foci in calcifying epithelial odontogenic tumors, hyaline droplets, small and large mineralized areas in adenomatoid odontogenic tumors, and a portion of ghost cells in calcifying odontogenic cysts. Positive reactivity was also observed in selected tumor cells in some of these tumors. No intracellular staining for enamelysin was detected in ameloblastomas or the ameloblastic portion of ameloblastic fibro-odontomas. Also, enamelysin was not detected in dentin, dysplastic dentinoid hyaline matrices, and cementum that were present within the tumors examined. Thus, taken together, our results suggest that the enamelysin-specific monoclonal antibody (203-1C7) may be utilized as a marker of early enamel development and that enamelysin may be involved in the pathogenesis of specific odontogenic tumors.
釉质溶解素是一种牙齿特异性蛋白酶,最初从猪牙釉质器官中分离出来,随后又从人成牙本质细胞中分离得到。由于这种蛋白酶被认为在牙齿发育中起重要作用,因此评估牙源性肿瘤中的釉质溶解素可能有助于我们理解此类病变的组织发生和细胞分化。针对合成的人釉质溶解素寡肽产生了一种单克隆抗体(203-1C7),并用于评估釉质溶解素在健康发育的牙胚和各种类型牙源性病变中的免疫定位。在牙胚中,仅在分泌性釉质中检测到釉质溶解素表达。因此,203-1C7可作为釉质基质发育和钙化后期的釉质特异性标志物。在牙源性病变中,成釉细胞纤维牙瘤和牙瘤的未成熟釉质基质中显示出强烈的釉质溶解素染色。此外,在钙化上皮性牙源性肿瘤的球状淀粉样物质和钙化灶、腺样牙源性肿瘤的透明滴、小和大的矿化区域以及钙化牙源性囊肿中的一部分幽灵细胞中也检测到了釉质溶解素。在其中一些肿瘤的选定肿瘤细胞中也观察到了阳性反应性。在成釉细胞瘤或成釉细胞纤维牙瘤的成釉细胞部分未检测到釉质溶解素的细胞内染色。此外,在所检查的肿瘤内的牙本质、发育异常的类牙本质透明基质和牙骨质中未检测到釉质溶解素。因此,综合来看,我们的结果表明,釉质溶解素特异性单克隆抗体(203-1C7)可作为早期釉质发育的标志物,并且釉质溶解素可能参与特定牙源性肿瘤的发病机制。